Revvity (NYSE:RVTY) Downgraded to Hold Rating by Wall Street Zen

Wall Street Zen lowered shares of Revvity (NYSE:RVTY) from a buy rating to a hold rating in a report issued on Sunday.

Other equities research analysts have also issued reports about the company. Sanford C. Bernstein began coverage on Revvity in a research note on Friday, June 26th. They set a “market perform” rating and a $115.00 price objective for the company. Robert W. Baird set a $117.00 price target on Revvity in a research note on Wednesday, May 6th. Barclays boosted their price target on Revvity from $95.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Thursday, May 7th. Weiss Ratings upgraded Revvity from a “sell (d+)” rating to a “hold (c-)” rating in a report on Thursday, July 30th. Finally, Stifel Nicolaus lowered their target price on shares of Revvity from $110.00 to $100.00 and set a “hold” rating on the stock in a research note on Wednesday, May 6th. Three research analysts have rated the stock with a Buy rating and twelve have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $108.36.

Revvity Trading Down 0.1%

RVTY stock opened at $116.71 on Friday. The company’s 50-day simple moving average is $109.62 and its 200-day simple moving average is $99.98. The company has a quick ratio of 1.50, a current ratio of 1.80 and a debt-to-equity ratio of 0.36. Revvity has a 52-week low of $81.22 and a 52-week high of $118.34. The firm has a market cap of $13.02 billion, a P/E ratio of 55.58, a PEG ratio of 2.13 and a beta of 1.07.

Revvity (NYSE:RVTY) last announced its earnings results on Tuesday, August 4th. The company reported $1.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.21 by $0.20. Revvity had a return on equity of 8.34% and a net margin of 8.16%.The firm had revenue of $729.69 million for the quarter, compared to analyst estimates of $702.96 million. During the same quarter last year, the firm posted $1.18 EPS. The business’s revenue was down 1.3% on a year-over-year basis. Revvity has set its FY 2026 guidance at 5.300-5.400 EPS. As a group, equities analysts forecast that Revvity will post 5.36 EPS for the current fiscal year.

Revvity Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 13th. Stockholders of record on Friday, October 23rd will be issued a dividend of $0.07 per share. The ex-dividend date is Friday, October 23rd. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.2%. Revvity’s dividend payout ratio is currently 13.33%.

Hedge Funds Weigh In On Revvity

Several large investors have recently made changes to their positions in the stock. KBC Group NV raised its position in shares of Revvity by 115.4% during the 4th quarter. KBC Group NV now owns 39,522 shares of the company’s stock worth $3,824,000 after purchasing an additional 21,174 shares during the period. Corient Private Wealth LLC boosted its position in Revvity by 985.0% during the 4th quarter. Corient Private Wealth LLC now owns 126,568 shares of the company’s stock valued at $12,245,000 after purchasing an additional 114,903 shares during the period. California State Teachers Retirement System boosted its position in Revvity by 19.8% during the 1st quarter. California State Teachers Retirement System now owns 133,809 shares of the company’s stock valued at $11,723,000 after purchasing an additional 22,075 shares during the period. Diamond Hill Capital Management Inc. grew its stake in Revvity by 6.3% during the 4th quarter. Diamond Hill Capital Management Inc. now owns 426,899 shares of the company’s stock worth $41,302,000 after buying an additional 25,233 shares during the last quarter. Finally, Bank of America Corp DE grew its stake in Revvity by 14.7% during the 1st quarter. Bank of America Corp DE now owns 880,503 shares of the company’s stock worth $77,141,000 after buying an additional 112,928 shares during the last quarter. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.